Clinical studies have demonstrated that sustaining viral suppression and maintaining higher CD4 count, mostly as a result of effective combination antiretroviral therapy, delay or prevent some AIDS/non-AIDS–defining complications, such as HIV-associated kidney disease. This evidence concerns the gene CD4 and AIDS.